MAG and breast carcinoma: Hagiwara K. et al., identified that MAG treatment has the ability to induce novel tumor suppressor microRNA-200c (miRNA-200c) which led to ZEB1 inhibition and E-cadherin induction in breast cancer cells (Table 1) [54].